Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

WALL STREET UP, MAIN STREET DOWN

On 4 December, all four major U.S. stock indices set new record highs, driven by euphoria over the prospect of COVID vaccines’ distribution and resumption of stimulus negotiations between Congress and the Trump administration.
The Dow gained 1 percent on the day, closing at 30,218.26. The NASDAQ rose 2.1 percent to 12,464.23. The Russell index bumped up 2 percent 1,882.14, and the S&P climbed 1.7 percent to close at 3,699.12.
It was the first time since January 2018 that the Dow, NASDAQ, Russell 2000 small-cap index, and S&P 500 set records on the same day, according to Dow Jones Market Data reported in the Wall Street Journal.
“As grim as the pandemic news may be over the next three or four months, the vaccine at the end of the tunnel will probably mean that the markets overlook that grim news,” George Ball, CEO of the Sanders Morris Harris investment firm, commented to the Journal.
Markets shrugged off November’s weak jobs report as well as a recent survey showing consumer confidence ebbing. Investors drew encouragement from president-elect Joe Biden’s selection of Janet Yellin to lead the U.S. Treasury Department, analysts agree.
Yellin has voiced support for continued economic stimulus and shown comfort with a continuation, at least for now, of the U.S. Federal Reserve’s low interest rates.
In a 3 December CNN interview, Biden also said he will keep the economy open and will not order another shutdown. 
TRENDPOST: As we keep noting, stock prices are floating on optimism and the Fed’s cheap money. Increasingly, analysts are in alignment with us that a sharp market correction is on the way.

Comments are closed.